NCT00649376View on ClinicalTrials.gov

Fasting Study of Fexofenadine Tablets 180 mg and Allegra® Tablets 180 mg

PHASE1CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

October 31, 2003

Primary Completion Date

November 30, 2003

Study Completion Date

November 30, 2003

Conditions
Healthy
Interventions
DRUG

Fexofenadine Tablets 180 mg

180mg, single dose fasting

DRUG

Allegra® Tablets 180 mg

180mg, single dose fasting

Trial Locations (1)

26505

Kendle International Inc., Morgantown

Sponsors
All Listed Sponsors
lead

Mylan Pharmaceuticals Inc

INDUSTRY

NCT00649376 - Fasting Study of Fexofenadine Tablets 180 mg and Allegra® Tablets 180 mg | Biotech Hunter | Biotech Hunter